A case study discussing the medicine eflornithine and how it can help cure African Sleeping Sickness.
The central issue of this case study is what should be done with mounting pressures to give up our company’s patent on eflornithine, a drug that can cure Human African trpanosomiasis, more commonly known as African Sleeping Sickness, a disease that attacks the nervous system.